Publication Name	World Journal of Experimental Medicine
Manuscript ID	80740
Country	India

Received	2022-10-10 18:26
Peer-Review Started	2022-10-10 18:28
To Make the First Decision
Return for Revision	2022-11-11 09:43
Revised	2022-11-18 05:07
Second Decision	2022-12-07 03:23
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2022-12-07 18:36
Articles in Press	2022-12-07 18:36
Publication Fee Transferred
Edit the Manuscript by Language Editor	2022-12-01 09:19
Typeset the Manuscript	2022-12-09 02:15
Publish the Manuscript Online	2022-12-09 04:16

ISSN	2220-315x (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Rheumatology
Manuscript Type	Letter to the Editor
Article Title	Can hydroxychloroquine be used for COVID-19-induced arthritis? A debatable hypothesis
Manuscript Source	Unsolicited Manuscript
All Author List	Raktim Swarnakar, Sankha Subhra Roy and Shiv Lal Yadav
Funding Agency and Grant Number
Corresponding Author	Raktim Swarnakar, MBBS, MD, Doctor, Department of Physical Medicine and Rehabilitation, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, Delhi, India. raktimswarnakar@hotmail.com
Key Words	COVID-19; Arthritis; Hydroxychloroquine; DMARDS; SARS-CoV-2; Post-COVID-19 arthritis
Core Tip	Hydroxychloroquine is a known disease-modifying antirheumatic drug and has antiviral properties. It had previously been used to treat viral arthritis. In this letter, using future research questions in the context of the evidence in the literature we debate whether hydroxychloroquine can be used in post-coronavirus disease 2019 arthritis.
Publish Date	2022-12-09 04:16
Citation	Swarnakar R, Roy SS, Yadav SL. Can hydroxychloroquine be used for COVID-19-induced arthritis? A debatable hypothesis. World J Exp Med 2022; 12(6): 108-110
URL	https://www.wjgnet.com/2220-315x/full/v12/i6/108.htm
DOI	https://dx.doi.org/10.5493/wjem.v12.i6.108

Full Article (PDF)	WJEM-12-108.pdf
Full Article (Word)	WJEM-12-108.docx
Manuscript File	80740_Auto_Edited-LM.docx
Answering Reviewers	80740-Answering reviewers.pdf
Audio Core Tip	80740-Audio core tip.aac
Conflict-of-Interest Disclosure Form	80740-Conflict-of-interest statement.pdf
Copyright License Agreement	80740-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	80740-Language certificate.pdf
Peer-review Report	80740-Peer-review(s).pdf
Scientific Misconduct Check	80740-Bing-Liu JH-2.jpg
Scientific Misconduct Check	80740-CrossCheck.jpg
Scientific Editor Work List	80740-Scientific editor work list.pdf